Table 1

 Summary of characteristics of patients with hepatic metastases derived from a variety of carcinomas and H19 level of expression in paraffin section samples of these metastases

CharacteristicAll patientsNo H19 expressionLow level H19 expressionHigh level H19 expression
Mean (SD; N) age at metastasis diagnosis (years)60.8 (13.3; 80)61.1 (9.33; 16)61.4 (17.07; 21)60.5 (12.79; 43)
Mean (SD; N) age at primary tumour diagnosis (years)59.75 (14.9; 54)64 (7.12; 9)58.6 (18.4; 16)59 (14.75; 29)
No. patients who died (%)57 (71)13 (23)11 (19)33 (58)
No. patients who remained alive (%)12 (15)1 (8)5 (42)6 (50)
Mean (SD; N) age at death (years)62.7 (12.3; 49)62.7 (9.87; 11)68.8 (10.93; 9)60.8 (13.2; 29)
Sex (%)
    Female45 (56)7 (16)11 (24)27 (60)
    Male35 (44)9 (26)10 (28)16 (46)
Type of primary carcinoma (%)
    Colorectal adenocarcinoma37 (46)6 (16)13 (35)18 (49)
    Breast carcinoma5 (6)14
    Pancreatic exocrine adenocarcinoma3 (4)21
    Pancreatic endocrine tumour2 (2.5)2
    Gastric adenocarcinoma3 (4)3
    Parotid gland adenoid cystic carcinoma1 (1.25)1
    Duodenal adenocarcinoma1 (1.25)1
    Urinary bladder transitional cell carcinoma1 (1.25)1
    Oesophageal adenocarcinoma1 (1.25)1
    Uncertain or unknown primary26 (32.5)7 (27)6 (23)13 (50)